Cite Filings / ALZN
Feed Companies Filings Check
Sign in

CIK 0001677077 · <br>Emerging growth company

Alzamend Neuro, Inc.

Sign in to watch
Ticker
ALZN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Apr 30
Incorporated
DE
Entity type
operating
EIN
811822909
Phone
844-722-6333
Business address
480 PEACHTREE ROAD NE, SECOND FLOOR, SUITE 103, ATLANTA, GA, 30326
Filings Insiders Search text
All 398 Financials 94 Shareholder Meetings 12 Executive Compensation 84 Insider Trading 170 Beneficial Ownership Interest 18 Business Combinations 72 Public Offerings 51 Regulation A Offering 25 Mutual Funds and ETFs 6 Others 34
›
Filed in
  1. No filings match these filters. Clear filters
  2. PRE 14A Proxy Proxy Statement (Preliminary) 2026-08-28
  3. DEF 14A Proxy Proxy Statement 2026-02-26
  4. PRE 14A Proxy Proxy Statement (Preliminary) 2026-02-09
  5. DEF 14A Proxy Proxy Statement 2025-03-13
  6. PRE 14A Proxy Proxy Statement (Preliminary) 2025-02-28
  7. DEF 14A Proxy Proxy Statement 2024-05-31
  8. PRE 14A Proxy Proxy Statement (Preliminary) 2024-05-10
  9. DEF 14A Proxy Proxy Statement 2024-03-25
  10. PRE 14A Proxy Proxy Statement (Preliminary) 2024-03-13
  11. DEF 14A Proxy Proxy Statement 2023-08-24
  12. PRE 14A Proxy Proxy Statement (Preliminary) 2023-08-10
  13. DEF 14A Proxy Proxy Statement 2023-03-31

Page 1 of 1 · 12 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…